Trajectory health is developing a novel semi-implantable, battery free device called the T.A.B. The T.A.B. has been designed for remote monitoring of clinical trial participants and measures key markers in the saliva. Saliva is a fantastic physiological medium for diagnostics and clinical monitoring and correlates significantly with serum levels. The device passively relays information over to a extraoral receiver in real time which can be accessed by any designated clinician. The device remains intraorally as long as required by the clinical or patient and is easily removed by a clinician or dentist.
REMOTE/ DIGITAL CLINICAL TRIALS REDUCE COSTS AND INCREASE SPEED TO MARKET
The T.A.B. has been designed to improve remote monitoring or participants in clinical trials. It allows companies to tailor the biomarkers and compounds measured based on the tiral.